Stock UniverseDerived research view · source repositories remain read-only

ALX Oncology Holdings Inc. (ALXO)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
29.44
Global Rank
2106
Market Cap
276.83M
Latest Close
1.54
RS Composite
-20.87% · G#2687

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-26.32%
3M
-30.32%
6M
16.67%
1Y
188.39%
3Y
-76.91%
5Y
-97.28%
10Y
-94.87%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 858.00K · 30-day average: 992.10K · Max drawdown over stored range: -99.64%

Research Snapshot

Relative Strength vs SPX

RS Composite-20.87%
20D RS-18.28%
60D RS-37.34%
120D RS-5.68%
Global RS Rank2687 · 19.91% percentile
Watch+Speculative RS Rank1645 · 21.55% percentile
Group ScopeWatch+Speculative
Primary RS Rank302 · 34.06% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank330 / 701
Primary Percentile53.07
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for ALXO.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1.1820000
Revenue Growth (YoY)-75.354%2600%2600%2600%2600%
Gross Profit0.1070000
Operating Income-43.663-83.555-127.436-170.278-142.467-100.846
Free Cash Flow-38.32-68.767-90.65-131.638-122.359-84.354
Free Cash Flow Per Share-2.073-1.706-2.227-3.062-2.345-1.572055849075929
EPS (Diluted) GAAP-2.755804-2.070628-3.033984-3.740715-2.584575-1.899999
EPS Growth
EPS Non-GAAP
Gross Margin9.052%2600%2600%2600%2600%
Operating Margin-3693.993%2600%2600%2600%2600%
Profit Margin-4309.814%2600%2600%2600%2600%
Free Cash Flow Margin-3241.963%2600%2600%2600%2600%
Shares Outstanding (Diluted)18.485340.308140.699642.987852.174953.6584
Shares Change (YoY)500.864%118.054%0.971%5.622%21.372%2.843%

SEC Quarterly Fundamentals

No processed quarterly rows for ALXO.